These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15 related articles for article (PubMed ID: 9311615)
1. Probenecid interferes with renal oxidative metabolism: a potential pitfall in its use as an inhibitor of drug transport. Masereeuw R; van Pelt AP; van Os SH; Willems PH; Smits P; Russel FG Br J Pharmacol; 2000 Sep; 131(1):57-62. PubMed ID: 10960069 [TBL] [Abstract][Full Text] [Related]
2. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data? Ward ES; Pollack GM; Brouwer KL Drug Metab Dispos; 2000 Dec; 28(12):1433-9. PubMed ID: 11095580 [TBL] [Abstract][Full Text] [Related]
3. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat. Savina PM; Brouwer KL Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724 [TBL] [Abstract][Full Text] [Related]
4. Hepatic disposition of acetaminophen and metabolites. Pharmacokinetic modeling, protein binding and subcellular distribution. Studenberg SD; Brouwer KL Biochem Pharmacol; 1993 Aug; 46(4):739-46. PubMed ID: 8363647 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid. von Moltke LL; Manis M; Harmatz JS; Poorman R; Greenblatt DJ Biopharm Drug Dispos; 1993 Mar; 14(2):119-30. PubMed ID: 8453022 [TBL] [Abstract][Full Text] [Related]
7. In vitro mechanisms of probenecid-associated alterations in acetaminophen glucuronide hepatic disposition. Turner KC; Brouwer KL Drug Metab Dispos; 1997 Sep; 25(9):1017-21. PubMed ID: 9311615 [TBL] [Abstract][Full Text] [Related]